|
US4200750A
(en)
|
1977-01-07 |
1980-04-29 |
Westwood Pharmaceuticals Inc. |
4-Substituted imidazo [1,2-a]quinoxalines
|
|
US6069143A
(en)
|
1994-12-20 |
2000-05-30 |
Smithkline Beecham Corporation |
Fibrinogen receptor antagonists
|
|
JP4430941B2
(ja)
|
2002-01-18 |
2010-03-10 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬
|
|
WO2003061567A2
(en)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
ATE448193T1
(de)
|
2002-01-18 |
2009-11-15 |
Merck & Co Inc |
ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
JP2005533058A
(ja)
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
|
|
AU2004240586A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
|
CL2004001120A1
(es)
|
2003-05-19 |
2005-04-15 |
Irm Llc |
Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
|
|
US20070043014A1
(en)
*
|
2003-10-01 |
2007-02-22 |
Merck & Co., Inc. |
3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
|
EP1697333A4
(en)
|
2003-12-17 |
2009-07-08 |
Merck & Co Inc |
(3,4-DISUBSTITUTED) PROPANE ACID BOXYLATES AS AGONISTS OF THE S1P (EDG) RECEPTOR
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
CA2583681A1
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
|
US7605269B2
(en)
|
2005-03-23 |
2009-10-20 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
|
|
WO2006115188A1
(ja)
|
2005-04-22 |
2006-11-02 |
Daiichi Sankyo Company, Limited |
ヘテロ環化合物
|
|
WO2006131336A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
|
|
BRPI0615133A2
(pt)
|
2005-08-23 |
2011-05-03 |
Irm Llc |
compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
|
|
WO2007088450A2
(en)
*
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
AU2007227274A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1P receptor modulating compounds
|
|
PL2003132T3
(pl)
|
2006-04-03 |
2014-10-31 |
Astellas Pharma Inc |
Pochodne oksadiazolu jako agoniści S1P1
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
PL2069335T3
(pl)
|
2006-09-08 |
2013-05-31 |
Actelion Pharmaceuticals Ltd |
Pochodne pirydyn-3-ylu jako środki immunomodulujące
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0808789A2
(pt)
|
2007-03-16 |
2014-08-12 |
Actelion Pharmaceuticals Ltd |
Compostos e composição farmacêutica de derivados aminopiridina e uso destes
|
|
MX2010003612A
(es)
|
2007-10-04 |
2010-04-30 |
Merck Serono Sa |
Derivados de oxadiazol.
|
|
KR20100092473A
(ko)
|
2007-11-01 |
2010-08-20 |
액테리온 파마슈티칼 리미티드 |
신규한 피리미딘 유도체
|
|
GB0725105D0
(en)
*
|
2007-12-21 |
2008-01-30 |
Glaxo Group Ltd |
Compounds
|
|
WO2009131090A1
(ja)
*
|
2008-04-21 |
2009-10-29 |
旭化成ファーマ株式会社 |
アミノ酸化合物
|
|
US8741923B2
(en)
*
|
2008-12-18 |
2014-06-03 |
Merck Serono Sa |
Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
|
|
EP2202232A1
(en)
*
|
2008-12-26 |
2010-06-30 |
Laboratorios Almirall, S.A. |
1,2,4-oxadiazole derivatives and their therapeutic use
|
|
EP2210890A1
(en)
*
|
2009-01-19 |
2010-07-28 |
Almirall, S.A. |
Oxadiazole derivatives as S1P1 receptor agonists
|
|
JP2012515787A
(ja)
|
2009-01-23 |
2012-07-12 |
ブリストル−マイヤーズ スクイブ カンパニー |
自己免疫疾患および炎症性疾患の処置におけるｓ１ｐアゴニストとしての置換オキサジアゾール誘導体
|
|
ES2405054T3
(es)
|
2009-01-23 |
2013-05-30 |
Bristol-Myers Squibb Company |
Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
|
|
WO2010085582A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
|
|
US8399451B2
(en)
*
|
2009-08-07 |
2013-03-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds
|
|
US9216972B2
(en)
|
2009-10-29 |
2015-12-22 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
|
ES2548683T3
(es)
|
2010-04-23 |
2015-10-20 |
Bristol-Myers Squibb Company |
Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1
|
|
US8822510B2
(en)
|
2010-07-20 |
2014-09-02 |
Bristol-Myers Squibb Company |
Substituted 3-phenyl-1,2,4-Oxadiazole compounds
|
|
EP2619190B1
(en)
|
2010-09-24 |
2015-08-12 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|